maple doctors glp-1 weight loss medications wegovy prescription Pill Becomes First Oral Weight-Loss Drug Approved in U.S Medicare's New $50 Weight Loss

Theyll monitor how your body is responding to the drug and make any needed changes

74 Besides the expected improvements in metabolism and hepatic steatosis, liver fibrosis markers, including the fibrosis-4 index, ferritin, and type IV collagen 7s, were observed to decrease after 24 weeks of treatment

Obesity is a complex, multifactorial disorder, characterized not only by excessive fat accumulation but also by its association with a wide range of complications

The most successful treatments currently available include glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), exemplified by semaglutide (approved in 2017, $19.9 billion sales in 2023) 3 and tirzepatide (approved in 2022, $5.3 billion sales in 2023) 4

If a patient experiences side effects, the dose escalation is delayed